Fingerprint
Dive into the research topics where Masaaki Ishida is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Active
-
Rac1阻害、Ca/MgイオンがiPS細胞由来網膜色素上皮細胞移植に与える影響
Ishida, M. (Principal Investigator)
Japan Society for the Promotion of Science
2024/04/01 → 2027/03/31
Project: Research Project
Research output
- 17 Article
-
Hypotony after 25-gauge pars plana vitrectomy with suturing all sclerotomies
Takahashi, S., Ueda-Consolvo, T., Takata, Y., Ishida, M., Yanagisawa, S. & Hayashi, A., 2026/02, In: PLoS ONE. 21, 2 February, e0341951.Research output: Contribution to journal › Article › peer-review
Open Access -
Aflibercept 2 mg biosimilar (Tyalia)—real-world experience from IRAN (ATRIA study)
International Retina Biosimilar Study Group (Inter BIOS Group), 2025/08, In: Eye (Basingstoke). 39, 11, p. 2159-2163 5 p.Research output: Contribution to journal › Article › peer-review
5 Link opens in a new tab Scopus citations -
Allogenic Transplantation of RPE Strips Lacking MHC Class II Can Avoid Rejection in Nonhuman Primate Eyes
Ozaki, A., Sugita, S., Ishida, M., Nishida, M., Iseki, K., Sakai, N., Hayashi, N., Shiina, T., Yokota, S., Ito, S. I., Fujihara, M., Kondo, M., Takahashi, M., Kurimoto, Y. & Mandai, M., 2025/06, In: Investigative Ophthalmology and Visual Science. 66, 6, 53.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Assessment of retinal pigment epithelium tears in eyes with submacular hemorrhage secondary to age-related macular degeneration
Ueda-Consolvo, T., Takahashi, S., Oiwake, T., Nakamura, T., Ishida, M., Yanagisawa, S. & Hayashi, A., 2025/12, In: Scientific Reports. 15, 1, 3606.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations -
FYB-201 Biosimilar ranibizumab (Ongavia/Ranivisio/Cimerli) Efficacy and Safety in Clinical Settings – FORCE study
International Retina Biosimilar Study Group (Inter BIOS Group), 2025/12, In: Eye (Basingstoke). 39, 17, p. 3129-3134 6 p.Research output: Contribution to journal › Article › peer-review
2 Link opens in a new tab Scopus citations